Global Shift in R&D

A new analysis of global biomedical research and development investments shows that the US is losing some of its dominance, as industry science funding in the US, in particular, has lagged just as countries in Asia and Oceania have been spending more on R&D.

The analysis of global R&D trends between 2007 and 2012, published in the New England Journal of Medicine, found that the US share of global biomedical research spending declined over the last five years from 51 percent to below 45 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Bit Less

R&D Concentration

Investment Boom

Mostly Down

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.